Takeaways: Health Canada’s approval of Fujirebio’s Lumipulse G NfL Blood and pTau217 Plasma assays brings two high‑demand, blood‑based neurology tests into the Canadian marke...
Browsing Tag: neurological disease monitoring
Takeaways: Health Canada’s approval of Fujirebio’s Lumipulse G NfL Blood and pTau217 Plasma assays brings two high‑demand, blood‑based neurology tests into the Canadian marke...